Page 205 - Read Online

Page 14 of 15 Molinari et al. Hepatoma Res 2018;4:56 I http://dx.doi.org/10.20517/2394-5079.2018.71

consecutive patients who underwent hepatic resection in 15 years. Arch Surg 1994;129:738-42.
14. Zhou XD, Tang ZY, Yang BH, Lin ZY, Ma ZC, Ye SL, Wu ZQ, Fan J, Qin LX, Zheng BH. Experience of 1000 patients who underwent
hepatectomy for small hepatocellular carcinoma. Cancer 2001;91:1479-86.
15. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver
transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
16. Allgaier HP, Deibert P, Zuber I, Olschewski M, Blum HE. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular
carcinoma. Lancet 1999;353:1676-7.
17. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation.
Ann Intern Med 1998;129:643-53.
18. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, Tzakis AG, Van Thiel DH, Carr B, Selby R. Hepatic resection versus
transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221-8; discussion 8-9.
19. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, Wong J. Improving survival results after resection of hepatocellular carcinoma: a
prospective study of 377 patients over 10 years. Ann Surg 2001;234:63-70.
20. Nagashima I, Hamada C, Naruse K, Osada T, Nagao T, Kawano N, Muto T. Surgical resection for small hepatocellular carcinoma. Surgery
1996;119:40-5.
21. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999;19:311-22.
22. Akriviadis EA, Llovet JM, Efremidis SC, Shouval D, Canelo R, Ringe B, Meyers WC. Hepatocellular carcinoma. Br J Surg 1998;85:1319-
31.
23. Siegel AB, McBride RB, El-Serag HB, Hershman DL, Brown RS Jr., Renz JF, Emond J, Neugut AI. Racial disparities in utilization of liver
transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol 2008;103:120-7.
24. Bryce CL, Chang CC, Angus DC, Arnold RM, Farrell M, Roberts MS. The Effect of race, sex, and insurance status on time-to-listing
decisions for liver transplantation. J Transplant 2010;2010:467976.
25. Yu JC, Neugut AI, Wang S, Jacobson JS, Ferrante L, Khungar V, Lim E, Hershman DL, Brown RS, Jr., Siegel AB. Racial and insurance
disparities in the receipt of transplant among patients with hepatocellular carcinoma. Cancer 2010;116:1801-9.
26. Kish JK, Yu M, Percy-Laurry A, Altekruse SF. Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in
Surveillance, Epidemiology, and End Results (SEER) Registries. J Natl Cancer Inst Monogr 2014;2014:236-43.
27. Sarpel U, Suprun M, Sofianou A, Berger Y, Tedjasukmana A, Sekendiz Z, Bagiella E, Schwartz ME. Disentangling the effects of race and
socioeconomic factors on liver transplantation rates for hepatocellular carcinoma. Clin Transplant 2016;30:714-21.
28. Vandenbroucke JP. Analytic approaches to observational studies with treatment selection bias. JAMA 2007;297:2077-8; auhor reply 8.
29. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M, Initiative
S. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology
2007;18:805-35.
30. Wong RJ, Ahmed A. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver
transplantation in African Americans: an analysis from UNOS/OPTN database. Clin Transplant 2014;28:755-61.
31. Kemmer N, Neff G, Secic M, Zacharias V, Kaiser T, Buell J. Ethnic differences in hepatocellular carcinoma: implications for liver
transplantation. Dig Dis Sci 2008;53:551-5.
32. Ananthakrishnan AN, Saeian K. Racial differences in liver transplantation outcomes in the MELD era. Am J Gastroenterol 2008;103:901-
10.
33. Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet 2002;359:287-93.
34. Lee TH, Shah N, Pedersen RA, Kremers WK, Rosen CB, Klintmalm GB, Kim WR. Survival after liver transplantation: is racial disparity
inevitable? Hepatology 2007;46:1491-7.
35. Ayloo S, Hurton S, Cwinn M, Molinari M. Impact of body mass index on outcomes of 48281 patients undergoing first time cadaveric liver
transplantation. World J Transplant 2016;6:356-69.
36. Tapper EB, Su GL. Does Karnofsky Performance Status of patients with cirrhosis on the transplant waitlist meet the eyeball test? Clin
Gastroenterol Hepatol 2016;14:1196-8.
37. Tandon P, Reddy KR, O’Leary JG, Garcia-Tsao G, Abraldes JG, Wong F, Biggins SW, Maliakkal B, Fallon MB, Subramanian RM,
Thuluvath P, Kamath PS, Thacker LR, Bajaj JS, North American Consortium for the Study of End-Stage Liver D. A Karnofsky performance
status-based score predicts death after hospital discharge in patients with cirrhosis. Hepatology 2017;65:217-24.
38. de Kock I, Mirhosseini M, Lau F, Thai V, Downing M, Quan H, Lesperance M, Yang J. Conversion of Karnofsky Performance Status (KPS)
and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of
PPS and KPS in prognostic tools. J Palliat Care 2013;29:163-9.
39. Strauss D, Shavelle R. An extended Kaplan-Meier estimator and its applications. Stat Med 1998;17:971-82.
40. Kalia M. Personalized oncology: recent advances and future challenges. Metabolism 2013;62 Suppl 1:S11-4.
41. Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, Albertson PC, Hamilton AS, Hunt WC, Potosky AL. Racial
and ethnic differences in advanced-stage prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2001;93:388-95.
42. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho
H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012;62:220-41.
43. Luedi PP, Dietrich FS, Weidman JR, Bosko JM, Jirtle RL, Hartemink AJ. Computational and experimental identification of novel human
imprinted genes. Genome Res 2007;17:1723-30.
44. Shah SA, Smith JK, Li Y, Ng SC, Carroll JE, Tseng JF. Underutilization of therapy for hepatocellular carcinoma in the medicare population.
Cancer 2011;117:1019-26.
45. Nathan H, Hyder O, Mayo SC, Hirose K, Wolfgang CL, Choti MA, Pawlik TM. Surgical therapy for early hepatocellular carcinoma in the
modern era: a 10-year SEER-medicare analysis. Ann Surg 2013;258:1022-7.